Keywords: avanir, sb, sign, deal, cold, sore, drug
Avanir and SB sign deal for cold sore drug
Article | 13 January 2000
Avanir Pharmaceuticals and SmithKline Beecham have signed a letterof intent under which the latter will market Avanir's docosanol 10% cream in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
